相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model
Hai-Jun Hu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer Immunotherapy
Zheng Liu et al.
CANCER RESEARCH (2021)
Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic
Luni Emdad et al.
SEMINARS IN CANCER BIOLOGY (2020)
IMMUNOTHERAPY Engineering cytokines and cytokine circuits
Aileen W. Li et al.
SCIENCE (2020)
Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma
Chune Yu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Factors Influencing Recombinant Protein Secretion Efficiency in Gram-Positive Bacteria: Signal Peptide and Beyond
Chong Peng et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
Alexander Thiem et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Akintunde Akinleye et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Mechanism of internalization of MDA-7/IL-24 protein and its cognate receptors following ligand-receptor docking
Anjan K. Pradhan et al.
Oncotarget (2019)
De novo design of potent and selective mimics of IL-2 and IL-15
Daniel-Adriano Silva et al.
NATURE (2019)
Interleukin-24 Regulates T Cell Activity in Patients With Colorectal Adenocarcinoma
Yang Zhang et al.
FRONTIERS IN ONCOLOGY (2019)
Mechanisms of Resistance to PD-1 and PD-L1 Blockade
Theodore S. Nowicki et al.
CANCER JOURNAL (2018)
Cutaneous melanoma: From pathogenesis to therapy (Review)
Giulia C. Leonardi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Recombinant MDA-7/IL24 Suppresses Prostate Cancer Bone Metastasis through Downregulation of the Akt/Mcl-1 Pathway
Anjan K. Pradhan et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Melanoma treatment in review
Beatriz Domingues et al.
IMMUNOTARGETS AND THERAPY (2018)
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy
Kevin A. Hay et al.
BLOOD (2017)
Novel therapy of prostate cancer employing a combination of viral-based immunotherapy and a small molecule BH3 mimetic
Siddik Sarkar et al.
ONCOIMMUNOLOGY (2016)
NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models
Deborah H. Charych et al.
CLINICAL CANCER RESEARCH (2016)
Essential role of HDAC6 in the regulation of PD-L1 in melanoma
M. Lienlaf et al.
MOLECULAR ONCOLOGY (2016)
Mda-7/IL-24 enhances sensitivity of B cell lymphoma to chemotherapy drugs
Ming Ma et al.
ONCOLOGY REPORTS (2016)
Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic
Siddik Sarkar et al.
ONCOTARGET (2015)
MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer
Mitchell E. Menezes et al.
ONCOTARGET (2015)
Novel Mechanism of MDA-7/IL-24 Cancer-Specific Apoptosis through SARI Induction
Rupesh Dash et al.
CANCER RESEARCH (2014)
Enhanced Prostate Cancer Gene Transfer and Therapy Using a Novel Serotype Chimera Cancer Terminator Virus (Ad.5/3-CTV)
Belal M. Azab et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Mitigating the toxic effects of anticancer immunotherapy
Tara C. Gangadhar et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
PD-1 and PD-L1 antibodies for melanoma
Katy K. Tsai et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Chemoprevention Gene Therapy (CGT): Novel Combinatorial Approach for Preventing and Treating Pancreatic Cancer
S. Sarkar et al.
CURRENT MOLECULAR MEDICINE (2013)
Critical Role of Lysine 123 in the Ubiquitin-Mediated Degradation of MDA-7/IL-24
Hui Tian et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2012)
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'
Aron M. Levin et al.
NATURE (2012)
Targeting the Immunoregulator SRA/CD204 Potentiates Specific Dendritic Cell Vaccine-Induced T-cell Response and Antitumor Immunity
Huanfa Yi et al.
CANCER RESEARCH (2011)
Acetylation of the Proto-Oncogene EVI1 Abrogates Bcl-xL Promoter Binding and Induces Apoptosis
Anjan Kumar Pradhan et al.
PLOS ONE (2011)
Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity
Rupesh Dash et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
mda-7/IL-24: A unique member of the IL-10 gene family promoting cancer-targeted toxicity
Rupesh Dash et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Adjuvant pegylated interferon α-2b therapy for melanoma
Bastian Schilling et al.
ONCOLOGY LETTERS (2010)
Genome-wide analysis of signal peptide functionality in Lactobacillus plantarum WCFS1
Geir Mathiesen et al.
BMC GENOMICS (2009)
Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24
Luni Emdad et al.
CANCER BIOLOGY & THERAPY (2009)
MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors
Adly Yacoub et al.
CANCER BIOLOGY & THERAPY (2008)
A cancer terminator virus eradicates both primary and distant human melanomas
D. Sarkar et al.
CANCER GENE THERAPY (2008)
Secretable chaperone grp170 enhances therapeutic activity of a novel tumor suppressor, mda-7/IL-24
Ping Gao et al.
CANCER RESEARCH (2008)
Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis
Moira Sauane et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Melanoma differentiation associated gene-7/interieukin-24 reverses multidrug resistance in human colorectal cancer cells
Luni Emdad et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Eradication of therapy-resistant human prostate tumors using a cancer terminator virus
Devanand Sarkar et al.
CANCER RESEARCH (2007)
Systematic screening of all signal peptides from Bacillus subtilis:: A powerful strategy in optimizing heterologous protein secretion in gram-positive bacteria
Ulf Brockmeier et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model
R. Miyahara et al.
CANCER GENE THERAPY (2006)
Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): Biologic outcome in advanced cancer patients
AW Tong et al.
MOLECULAR THERAPY (2005)
Clinical and local biological effects of an intraturnoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study
CC Cunningham et al.
MOLECULAR THERAPY (2005)
MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine
M Sauane et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2003)
The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24
EG Caudell et al.
JOURNAL OF IMMUNOLOGY (2002)
分享论文
